{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:55:28Z","timestamp":1791388528113,"version":"4.3.3"},"reference-count":53,"publisher":"Elsevier","isbn-type":[{"value":"9780443431906","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.pmbts.2026.01.001","type":"book-chapter","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T12:20:46Z","timestamp":1769775646000},"page":"229-246","source":"Crossref","is-referenced-by-count":3,"title":["Fecal microbiota transplantation in liver diseases: Therapeutic potential and associated risks"],"prefix":"10.1016","author":[{"given":"Jayeeta","family":"Bhowmick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arka","family":"Bagchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pmbts.2026.01.001_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"Journal of Hepatology"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib2","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"403","author":"Naghavi","year":"2024","journal-title":"The Lancet"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut\u2013liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib4","first-page":"854","article-title":"Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis","volume":"44","author":"Eiseman","year":"1958","journal-title":"Surgery"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib5","unstructured":"Research C for BE and. REBYOTA. FDA; 2022."},{"key":"10.1016\/bs.pmbts.2026.01.001_bib6","unstructured":"Research C for BE and. VOWST. FDA; 2023."},{"key":"10.1016\/bs.pmbts.2026.01.001_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal Infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"Nood","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib8","unstructured":"Small intestinal bacterial overgrowth in chronic liver disease: an updated systematic review and meta-analysis of case-control studies - eClinicalMedicine n.d. https:\/\/www.thelancet.com\/journals\/eclinm\/article\/PIIS2589\u20135370%2824%2900603\u20135\/fulltext?utm_source=chatgpt.com (Accessed September 28, 2025)."},{"key":"10.1016\/bs.pmbts.2026.01.001_bib9","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.30690","article-title":"Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial","volume":"70","author":"Bajaj","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133410","article-title":"Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis","volume":"4","author":"Bajaj","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib11","article-title":"Stool banking for fecal microbiota transplantation: methods and operations at a large stool bank","volume":"11","author":"Chen","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib12","doi-asserted-by":"crossref","unstructured":"Cammarota G, Ianiro G, Kelly CR, Mullish BH, Allegretti JR, Kassam Z, et al. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 2019. https:\/\/doi.org\/10.1136\/gutjnl-2019\u2013319548.","DOI":"10.1136\/gutjnl-2019-319548"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib13","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3390\/jcm9061757","article-title":"Fecal microbiota transplantation: screening and selection to choose the optimal donor","volume":"9","author":"Bibb\u00f2","year":"2020","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib14","article-title":"of the. Fecal microbiota for transplantation: safety alert - risk of serious adverse events likely due to transmission of pathogenic organisms","author":"Commissioner","year":"2024","journal-title":"FDA"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib15","article-title":"of the. Fecal microbiota for transplantation: safety communication- risk of serious adverse reactions due to transmission of multi-drug resistant organisms","author":"Commissioner","year":"2024","journal-title":"FDA"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib16","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant","volume":"381","author":"DeFilipp","year":"2019","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib17","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000363","article-title":"Validation of high-sensitivity severe acute respiratory syndrome coronavirus 2 testing for stool\u2014toward the new normal for fecal microbiota transplantation","volume":"12","author":"Babiker","year":"2021","journal-title":"Clinical and Translational Gastroenterology"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib18","doi-asserted-by":"crossref","first-page":"21.e00161","DOI":"10.1128\/JCM.00161-21","article-title":"Fecal microbiota transplantation donor screening updates and research gaps for solid organ transplant recipients","volume":"60","author":"Mehta","year":"2022","journal-title":"J\u00a0Clin Microbiol."},{"issue":"6","key":"10.1016\/bs.pmbts.2026.01.001_bib19","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1053\/j.gastro.2020.08.039","article-title":"Monitoring fecal microbiota transplantation practice in a rapidly evolving health and regulatory environment","volume":"159","author":"Kelly","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/2050640620967898","article-title":"A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group","volume":"9","author":"Keller","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jhep.2024.12.047","article-title":"Microbiota transplant for hepatic encephalopathy in cirrhosis: the THEMATIC trial","volume":"83","author":"Bajaj","year":"2025","journal-title":"Journal of Hepatology"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib22","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.gastro.2024.01.008","article-title":"AGA clinical practice guideline on fecal microbiota-based therapies for select gastrointestinal diseases","volume":"166","author":"Peery","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3350\/cmh.2020.0057","article-title":"Fecal microbiota transplantation in alcohol related liver diseases","volume":"26","author":"Shasthry","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jhep.2018.10.019","article-title":"Microbiome as a therapeutic target in alcohol-related liver disease","volume":"70","author":"Sarin","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib26","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib27","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jceh.2022.01.001","article-title":"Long-term outcomes of stool transplant in alcohol-associated hepatitis-analysis of clinical outcomes, relapse, gut microbiota and comparisons with standard care","volume":"12","author":"Philips","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12072-022-10438-0","article-title":"Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial","volume":"17","author":"Pande","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.70007","article-title":"Impact of fecal microbiota transplantation in severe alcoholic hepatitis: a systematic review and meta\u2010analysis","volume":"8","author":"Taha","year":"2024","journal-title":"JGH Open"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12072-022-10312-z","article-title":"Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial","volume":"16","author":"Sharma","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/srep26800","article-title":"Impaired gut-liver-brain axis in patients with cirrhosis","volume":"6","author":"Ahluwalia","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","article-title":"EASL clinical practice guidelines on the management of hepatic encephalopathy","volume":"77","author":"Montagnese","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib33","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib34","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.30690","article-title":"Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial","volume":"70","author":"Bajaj","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jhep.2024.12.047","article-title":"Microbiota transplant for hepatic encephalopathy in cirrhosis: the THEMATIC trial","volume":"83","author":"Bajaj","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib36","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J\u00a0Hepatol."},{"key":"10.1016\/bs.pmbts.2026.01.001_bib37","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3748\/wjg.v30.i8.833","article-title":"Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: mechanism, clinical evidence, and prospect","volume":"30","author":"Qiu","year":"2024","journal-title":"World J Gastroenterol"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib38","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.14309\/ajg.0000000000000661","article-title":"Allogenic fecal microbiota transplantation in patients with nonalcoholic fatty liver disease improves abnormal small intestinal permeability: a randomized control trial","volume":"115","author":"Craven","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib39","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep4.1601","article-title":"Donor fecal microbiota transplantation alters gut microbiota and metabolites in obese individuals with steatohepatitis","volume":"4","author":"Witjes","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib40","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2541035","article-title":"Consecutive fecal microbiota transplantation for metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial","volume":"17","author":"Groenewegen","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1470185","article-title":"The effect of gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review and network meta-analysis","volume":"11","author":"Song","year":"2025","journal-title":"Front Nutr"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib42","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.3390\/jcm10122605","article-title":"Fecal microbiota transplantation in patients with HBV infection or other chronic liver diseases: update on current knowledge and future perspectives","volume":"10","author":"Paratore","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib43","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s10620-020-06246-x","article-title":"Fecal microbiota transplantation in hepatitis B e antigen-positive chronic hepatitis B patients: a pilot study","volume":"66","author":"Chauhan","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib44","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/hep.29008","article-title":"Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy","volume":"65","author":"Ren","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib45","article-title":"Fecal microbiota transplantation alters the outcome of hepatitis B virus infection in mice","volume":"12","author":"Wang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib46","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fcimb.2020.00341","article-title":"Role of microbiota in pathogenesis and management of viral hepatitis","volume":"10","author":"Sehgal","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib47","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2020.10.056","article-title":"Chronic liver diseases and the microbiome\u2014translating our knowledge of gut microbiota to management of chronic liver disease","volume":"160","author":"Acharya","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib48","unstructured":"Recommendations for testing, managing, and treating hepatitis C | HCV guidance n.d\u00a0https:\/\/www.hcvguidelines.org\/ (Accessed September 29, 2025)."},{"key":"10.1016\/bs.pmbts.2026.01.001_bib49","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on hepatitis E virus infection. J Hepatol. 2018;68:1256\u201371. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.005.","DOI":"10.1016\/j.jhep.2018.03.005"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1053\/j.gastro.2020.09.038","article-title":"Fecal microbiota transplantation is highly effective in real-world practice: initial results from the FMT national registry","volume":"160","author":"Kelly","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib51","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/cid\/civ247","article-title":"Fatal aspiration pneumonia as a complication of fecal microbiota transplant","volume":"61","author":"Baxter","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib52","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/cix684","article-title":"Early antibiotic use after fecal microbiota transplantation increases risk of treatment failure","volume":"66","author":"Allegretti","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/bs.pmbts.2026.01.001_bib53","unstructured":"Research C for BE and. Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies 2022. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/enforcement-policy-regarding-investigational-new-drug-requirements-use-fecal-microbiota (Accessed September 29, 2025)."}],"container-title":["Progress in Molecular Biology and Translational Science","Live Biotherapeutics: Advancing Microbial Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117326000013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117326000013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:28:47Z","timestamp":1791386927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117326000013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443431906"],"references-count":53,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2026.01.001","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}